These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3543144)

  • 21. IgA bullous pemphigoid: a distinct blistering disorder. Case report and review of the literature.
    Jones RR; Goolamali SK
    Br J Dermatol; 1980 Jun; 102(6):719-25. PubMed ID: 7000138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Childhood benign chronic bullous dermatosis. Differential diagnosis with dermatitis herpetiformis and bullous pemphigoid].
    Casanova JM; Vives P; Hernanz JM; Cimadevilla JC; González CM
    An Esp Pediatr; 1985 Jan; 22(1):37-42. PubMed ID: 3885812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pemphigus and pemphigoid].
    Stewart WM
    Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cells in bullous pemphigoid. Presence of activated CD4+ T cells at the basement membrane zone in pre- and peri-bullous skin.
    Michalaki H; Nicolas JF; Kanitakis J; Machado P; Roche P; Thivolet J
    Reg Immunol; 1990-1991; 3(3):151-5. PubMed ID: 1982989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria.
    Blank M; Gisondi P; Mimouni D; Peserico A; Piaserico S; Shoenfeld Y; Reunala T; Zambruno G; Di Zenzo G; Girolomoni G
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S20-5. PubMed ID: 16466621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A possible interaction between periostin and CD163
    Fujimura T; Kakizaki A; Furudate S; Aiba S
    Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ultrastructural localization of IgA deposits in chronic bullous disease of childhood (CBDC).
    Dabrowski J; Chorzelski TP; Jablońska S; Kraińska T; Jarzabek-Chorzelska M
    J Invest Dermatol; 1979 Jun; 72(6):291-5. PubMed ID: 376753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease.
    Rose C; Dieterich W; Bröcker EB; Schuppan D; Zillikens D
    J Am Acad Dermatol; 1999 Dec; 41(6):957-61. PubMed ID: 10570380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and quantification of subsets of mononuclear inflammatory cells in melanocytic and other human tumors.
    Nestor MS; Cochran AJ
    Pigment Cell Res; 1987; 1(1):22-7. PubMed ID: 3507659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving concept of IgA linear dermatosis.
    Chorzelski T; Jablonska S
    Semin Dermatol; 1988 Sep; 7(3):225-32. PubMed ID: 3153448
    [No Abstract]   [Full Text] [Related]  

  • 33. [An unusual clinical form of pemphigus vulgaris].
    Guggenberger K; Maciejewski W; Scherer R
    Hautarzt; 1979 Jan; 30(1):33-5. PubMed ID: 370064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemphigus and pemphigoid antigens are expressed in human amnion epithelium.
    Robinson HN; Anhalt GJ; Patel HP; Takahashi Y; Labib RS; Diaz LA
    J Invest Dermatol; 1984 Sep; 83(3):234-7. PubMed ID: 6381609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].
    Ambach A; Zillikens D; Klingert B; Hartmann AA; Burg G
    Hautarzt; 1992 Feb; 43(2):81-5. PubMed ID: 1548132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct immunofluorescence in cutaneous vesiculobullous lesions.
    Inchara YK; Rajalakshmi T
    Indian J Pathol Microbiol; 2007 Oct; 50(4):730-2. PubMed ID: 18306538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies.
    Tani M; Shimizu R; Ban M; Murata Y; Tamaki A
    Arch Dermatol; 1984 Nov; 120(11):1497-501. PubMed ID: 6388508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
    Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
    Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-helper cell activation in bullous pemphigoid.
    Schaller J; Haustein UF; Fiebig H
    Acta Derm Venereol; 1987; 67(6):520-3. PubMed ID: 2451379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear dermo-epidermal IgA deposition in bullous pemphigoid.
    van Joost T; Faber WR; Westerhof W; de Mari F
    Acta Derm Venereol; 1979; 59(5):463-5. PubMed ID: 93374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.